Celrixafor Injection
By Celrixafor
Rx
1 Injection in a Vial

Composition
Plerixafor(24mg)

Manufacturer - Celon Laboratories Ltd
Plot No 264, Patrika Nagar Madhapur, Hitech City Hyderabad, Telangana India - 500081

Expires on or after
July, 2025

liver
Limited information is currently available regarding the use of Celrixafor Injection in individuals with liver disease. It is imperative to seek guidance from your healthcare provider before using this medication to ensure its safety and effectiveness for patients with liver issues. Consulting with your doctor is crucial to assess any potential risks or modifications that may be necessary when considering the use of Celrixafor Injection in relation to liver health.

kidney
Celrixafor Injection should be used carefully in patients with kidney disease. The dosage of Celrixafor Injection might need to be adjusted. Consult your doctor for guidance.

alcohol
Consult your doctor when consuming alcohol with Celrixafor Injection.

driving
It is not known if Celrixafor Injection impacts driving. Avoid driving if you have symptoms affecting focus or reaction time.

pregnancy
Celrixafor Injection is not safe to use during pregnancy as it poses a risk to the developing baby. However, in life-threatening situations, a doctor may prescribe it if benefits outweigh risks. Please consult your doctor for advice.

breastfeeding
Caution is advised when considering the use of Celrixafor Injection during breastfeeding as it may not be safe. Limited human studies indicate potential harm to the baby as the drug can pass into breastmilk. It is recommended to consult a healthcare provider.
Habit Forming | No |
Chemical Class | Phenylmethylamines |
Therapeutic Class | - |
Action Class | Hematopoietic stem cell mobilizer |
₹72000
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 01-Oct-2024